Healing for every body

Where to buy
Where to buy
  • Packaging image of Cutimed Siltec Sorbact 10x10 cm
  • Cutimed Siltec Sorbact wound dressing with a white Siltec foam layer for absorption and a green Sorbact Technology layer for infection management.
  • Product facts visualizing low to moderate superficial infected

Cutimed® Siltec® Sorbact®

is a bacteria and fungi binding wound dressing, based on Sorbact Technology. It consists of a Sorbact DACC™-coated wound contact layer, combined with an absorbent polyurethane foam that contains superabsorbent stripes. 
  • Prevents and treats wound infection
  • Safe removal of bacteria, fungi and endotoxins
  • Effective against most common resistant pathogens

Intended Purpose

Indications: Cutimed Siltec Sorbact is intended for use in management of clean, contaminated, colonized or infected low to moderate exuding wounds, such as surgical wounds, traumatic wounds, pressure ulcers, diabetic foot ulcers and leg ulcers. It is intended to be used on superficial wounds. 

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 7 days. 

Watch videos on how to cut and apply the product
- For use around toes and fingers

- For use between toes and fingers

- For use between multiple toes or fingers

- For use on elbows

Learn about the product and how to apply it

Learn about the products' mode of action

Product benefits

Symbol of a shield representing infection prevention

Prevents and treats wound infection

Sorbact Technology dressings reduce bioburden and support effective wound healing, with no known contraindications and low risk of allergies1, 2, 3, 4, 5, 6.
Symbol of looped threads to visualize that the product inhibits the growth of bacteria.

Safe removal of bacteria, fungi and endotoxins

Sorbact Technology dressings irreversibly bind and remove bacteria, without the release of active agents to the wound5. Development of bacterial or fungal resistance is not expected.
Symbol showing crossed out pathogens, which stands for effectiveness against the most common resistant ones

Effective against most common resistant pathogens

In vitro tests show that Sorbact Technology dressings are able to inhibit the growth of the Top 5 World Health Organization (WHO) pathogens.

Product facts

Superficial

Infected

Low to moderate

How to use

1. Prepare the wound and surrounding skin according to local clinical practice. Ensure that the surrounding skin is clean and dry.

2. Choose an appropriate dressing that covers the wound and overlaps the wound edges. (A)

3. Remove the dressing from the peel pouch using an aseptic technique.

4. If required, the dressing may be cut using an aseptic technique to suit various wound shapes and locations. Discard unused pieces of the dressing.

5. Ensure that the Sorbact wound contact layer comes into direct contact with the complete wound surface to allow microorganisms to bind to the dressing. (B)

6. Fixate with an elastic bandage or skin friendly tape.

7. The dressing change frequency depends on exudate levels and the overall condition of the wound and surrounding skin. Should the clinical condition allow, the dressing can be left in place for up to 7 days.

How to Remove

Gently remove any additional fixation and the dressing from the wound and discard.

Product specifications

Product
Essity Product Code
Size
Pack Quantity
Cutimed® Siltec® Sorbact® 7276730 5 cm x 6 cm 10
Cutimed® Siltec® Sorbact® 7276731 Ø 4.5 cm 10
Cutimed® Siltec® Sorbact® 7276732 Ø 4.5 cm 10
Cutimed® Siltec® Sorbact® 7276733 10 cm x 10 cm 10
Cutimed® Siltec® Sorbact® 7276734 15 cm x 15 cm 10
Cutimed® Siltec® Sorbact® 7276735 10 cm x 20 cm 10
Cutimed® Siltec® Sorbact® 7276736 20 cm x 20 cm 5
Cutimed® Siltec® Sorbact® 7276738 16 cm x 24 cm 5

Medical References

1 Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.
2 Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.
3 Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.
4 Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.
5 Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.
6 Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.

Would you like to find out more about this product and how it can help your patients?

Contact us

Clinical Evidence

On this page, you can view and explore a selection of clinical studies that underline the performance of the Cutimed portfolio.

Discover more

Instruction for use

Please make sure to always follow the instructions for use, including the safety information provided with the product. Not at hand? Find the needed safety information in this database!

Cutimed IFUs